Selective Toxicity and Antibiotics
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
At the Bayer Laboratories of the IG Farben corporation in Germany, a group of
researchers led by Gerhard Domagk created Prontosil, the first sulfonamide and
the first antibacterial antibiotic that was sold commercially, in 1932. Paul
Ehrlich developed the science of synthetic antibiotic chemotherapy and
antibacterials in Germany in the late 1880s. Ehrlich observed that although
some dyes colored bacterial, animal, or human cells, others did not. He went on
to suggest that it would be feasible to develop compounds that would function
as a selective medication, attaching to and eliminating germs without
endangering the human host. He found the synthetic antibacterial Salvarsan,
now known as arsphenamine, to be a medicinally beneficial medication after
testing hundreds of dyes against different organisms. Antibiotics are frequently
categorized according to their spectrum of activity, chemical makeup, or mode
of action. More precisely, broad spectrum antibiotics treat a variety of bacteria,
while narrow spectrum antibiotics target particular bacterial species, such as
Gram-positive or Gram-negative bacteria. Three new classes of antibacterial
antibiotics have been introduced into clinical usage after a 40-year break in the
discovery of new antibacterial chemical classes: cyclic lipopeptides (like
daptomycin), glycylcyclines (like tigecycline), and oxazolidinones (like
linezolid). A variety of negative consequences have been linked to several
antibacterials. Depending on the antibiotics used, the microscopic organisms
targeted, and the patient, side effects might range from minor to quite
dangerous. Newer medications frequently have less established safety profiles
than those with a lengthy history of use. Fever, nausea, and severe allergic
reactions, such as photodermatitis and anaphylaxis, are among the side effects.
Diarrhea is a common side effect that arises from a change in the species
composition of gut flora, which can lead to an excess of harmful bacteria like
Clostridium difficile. Antibacterials may also have an impact on the vaginal
flora, which could result in an overabundance of Candida yeast species in the
vulva-vaginal region. Interactions with other medications can cause additional
side effects. For example, taking a quinolone antibiotic along with a systemic
corticosteroid increases the risk of tendon injury.
